FDA Approves Revolutionary Twice-Yearly HIV Prevention Drug
18.06.2025, 22:00
The FDA has approved lenacapavir, which is branded as Yeztugo®, a groundbreaking injectable drug providing HIV prevention with just two shots a year. This treatment, developed by Gilead Sciences, is the first of its kind to offer six months of protection against HIV, marking a significant...
